相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
2727872-68-4
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥1686.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥920.0 |
| 规格: | 5 mg | 产品价格: | ¥2200.0 |
| 规格: | 10 mg | 产品价格: | ¥3100.0 |
| 规格: | 25 mg | 产品价格: | ¥5288.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
SRI-42127
CAS No. : 2727872-68-4
MCE 国际站:SRI-42127
产品活性:SRI-42127 是一种 HuR 易位抑制剂。HuR 是一种与 ARE 元件结合的 RNA 调节因子,HuR 易位可促进胶质细胞中炎性细胞因子的产生。而 SRI-42127 能够破坏 mRNA 稳定性并抑制基因启动子激活。SRI-42127 还抑制小胶质细胞活化,减弱中性粒细胞和单核细胞的募集/趋化作用。
作用靶点:Interleukin Related
In Vitro: SRI-42127 (0.05-1 μM; 24 h) blocks HuR cytoplasmic translocation stimulated by LPS (1 μg/mL) in primary microglia.
SRI-42127 (0.05-1 μM; 24 h) suppresses inflammatory cytokine and chemokine mRNA in activated Primary microglia cells (PMG).
SRI-42127 (0.5 μM and 1 μM; 24 h) blocks glial-produced chemoattraction/migration signals for neutrophils and monocytes.
In Vivo: SRI-42127 (15 mg/kg; i.p.; single dose) suppresses HuR translocation and the activation of microglia in mice model.
相关产品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Differentiation Inducing Compound Library | Angiogenesis-Related Compound Library | Cytokine Inhibitors Library | Resatorvid | Disulfiram | Polyinosinic-polycytidylic acid | Deucravacitinib | Raleukin | Apilimod | Tocilizumab | Oxidopamine hydrobromide | Dupilumab | Theophylline | LMT-28 | Secukinumab | Clofazimine | Benzbromarone | Sodium metatungstate | Hydrocortisone hemisuccinate | SC144 | Diacerein | Muscone | JTE-607 | Ixekizumab | IL-17A inhibitor 1 | APY0201 | Vidofludimus | Prednisone acetate | Semapimod tetrahydrochloride | ODN 2216 | Triamcinolone
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The OP9-DL1 System: Generation of T-Lymphocytes from Embryonic or Hematopoietic Stem Cells In Vitro
N 3M5, Canada 1 Corresponding author (jczp@sri.utoronto.ca ) INTRODUCTION Differentiation of mouse embryonic stem cells (ESCs) or hematopoietic stem cells (HSCs) from fetal liver or bone marrow into T-lymphocytes can be achieved in vitro
技术资料暂无技术资料 索取技术资料


















